T 1483/18 (Botulinum neurotoxin composition / IPSEN) of 18.06.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T148318.20210618
- Date of decision
- 18 June 2021
- Case number
- T 1483/18
- Petition for review of
- -
- Application number
- 05757842.9
- IPC class
- A61K 47/30A61K 38/48
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITIONS COMPRISING BOTULINUM NEUROTOXIN, A NON IONIC SURFACTANT, SODIUM CHLORIDE AND SUCROSE
- Applicant name
- Ipsen Biopharm Limited
- Opponent name
- Merz Pharma GmbH & Co. KGaA
ALLERGAN, INC.
Daewoong Pharmaceutical Co., Ltd. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) (2007)European Patent Convention Art 54(2) (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)
- Keywords
- Amendments - added subject-matter (no)
Sufficiency of disclosure - (yes)
Novelty - implicit disclosure (no)
Inventive step - (yes) - Catchword
- -
- Cited cases
- T 1063/07
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent on the basis of the claims of the main request filed with letter of 16 June 2021 and a description to be adapted thereto.